Cargando…
Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic
There is an urgent need for inexpensive new technologies that enable fast, reliable, and scalable detection of viruses. Here, we repurpose the type III CRISPR-Cas system for sensitive and sequence-specific detection of SARS-CoV-2. RNA recognition by the type III CRISPR complex triggers Cas10-mediate...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157118/ https://www.ncbi.nlm.nih.gov/pubmed/34075364 http://dx.doi.org/10.1016/j.xcrm.2021.100319 |
_version_ | 1783699609032327168 |
---|---|
author | Santiago-Frangos, Andrew Hall, Laina N. Nemudraia, Anna Nemudryi, Artem Krishna, Pushya Wiegand, Tanner Wilkinson, Royce A. Snyder, Deann T. Hedges, Jodi F. Cicha, Calvin Lee, Helen H. Graham, Ava Jutila, Mark A. Taylor, Matthew P. Wiedenheft, Blake |
author_facet | Santiago-Frangos, Andrew Hall, Laina N. Nemudraia, Anna Nemudryi, Artem Krishna, Pushya Wiegand, Tanner Wilkinson, Royce A. Snyder, Deann T. Hedges, Jodi F. Cicha, Calvin Lee, Helen H. Graham, Ava Jutila, Mark A. Taylor, Matthew P. Wiedenheft, Blake |
author_sort | Santiago-Frangos, Andrew |
collection | PubMed |
description | There is an urgent need for inexpensive new technologies that enable fast, reliable, and scalable detection of viruses. Here, we repurpose the type III CRISPR-Cas system for sensitive and sequence-specific detection of SARS-CoV-2. RNA recognition by the type III CRISPR complex triggers Cas10-mediated polymerase activity, which simultaneously generates pyrophosphates, protons, and cyclic oligonucleotides. We show that all three Cas10-polymerase products are detectable using colorimetric or fluorometric readouts. We design ten guide RNAs that target conserved regions of SARS-CoV-2 genomes. Multiplexing improves the sensitivity of amplification-free RNA detection from 10(7) copies/μL for a single guide RNA to 10(6) copies/μL for ten guides. To decrease the limit of detection to levels that are clinically relevant, we developed a two-pot reaction consisting of RT-LAMP followed by T7-transcription and type III CRISPR-based detection. The two-pot reaction has a sensitivity of 200 copies/μL and is completed using patient samples in less than 30 min. |
format | Online Article Text |
id | pubmed-8157118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-81571182021-05-28 Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic Santiago-Frangos, Andrew Hall, Laina N. Nemudraia, Anna Nemudryi, Artem Krishna, Pushya Wiegand, Tanner Wilkinson, Royce A. Snyder, Deann T. Hedges, Jodi F. Cicha, Calvin Lee, Helen H. Graham, Ava Jutila, Mark A. Taylor, Matthew P. Wiedenheft, Blake Cell Rep Med Report There is an urgent need for inexpensive new technologies that enable fast, reliable, and scalable detection of viruses. Here, we repurpose the type III CRISPR-Cas system for sensitive and sequence-specific detection of SARS-CoV-2. RNA recognition by the type III CRISPR complex triggers Cas10-mediated polymerase activity, which simultaneously generates pyrophosphates, protons, and cyclic oligonucleotides. We show that all three Cas10-polymerase products are detectable using colorimetric or fluorometric readouts. We design ten guide RNAs that target conserved regions of SARS-CoV-2 genomes. Multiplexing improves the sensitivity of amplification-free RNA detection from 10(7) copies/μL for a single guide RNA to 10(6) copies/μL for ten guides. To decrease the limit of detection to levels that are clinically relevant, we developed a two-pot reaction consisting of RT-LAMP followed by T7-transcription and type III CRISPR-based detection. The two-pot reaction has a sensitivity of 200 copies/μL and is completed using patient samples in less than 30 min. Elsevier 2021-05-27 /pmc/articles/PMC8157118/ /pubmed/34075364 http://dx.doi.org/10.1016/j.xcrm.2021.100319 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Report Santiago-Frangos, Andrew Hall, Laina N. Nemudraia, Anna Nemudryi, Artem Krishna, Pushya Wiegand, Tanner Wilkinson, Royce A. Snyder, Deann T. Hedges, Jodi F. Cicha, Calvin Lee, Helen H. Graham, Ava Jutila, Mark A. Taylor, Matthew P. Wiedenheft, Blake Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic |
title | Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic |
title_full | Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic |
title_fullStr | Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic |
title_full_unstemmed | Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic |
title_short | Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic |
title_sort | intrinsic signal amplification by type iii crispr-cas systems provides a sequence-specific sars-cov-2 diagnostic |
topic | Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157118/ https://www.ncbi.nlm.nih.gov/pubmed/34075364 http://dx.doi.org/10.1016/j.xcrm.2021.100319 |
work_keys_str_mv | AT santiagofrangosandrew intrinsicsignalamplificationbytypeiiicrisprcassystemsprovidesasequencespecificsarscov2diagnostic AT halllainan intrinsicsignalamplificationbytypeiiicrisprcassystemsprovidesasequencespecificsarscov2diagnostic AT nemudraiaanna intrinsicsignalamplificationbytypeiiicrisprcassystemsprovidesasequencespecificsarscov2diagnostic AT nemudryiartem intrinsicsignalamplificationbytypeiiicrisprcassystemsprovidesasequencespecificsarscov2diagnostic AT krishnapushya intrinsicsignalamplificationbytypeiiicrisprcassystemsprovidesasequencespecificsarscov2diagnostic AT wiegandtanner intrinsicsignalamplificationbytypeiiicrisprcassystemsprovidesasequencespecificsarscov2diagnostic AT wilkinsonroycea intrinsicsignalamplificationbytypeiiicrisprcassystemsprovidesasequencespecificsarscov2diagnostic AT snyderdeannt intrinsicsignalamplificationbytypeiiicrisprcassystemsprovidesasequencespecificsarscov2diagnostic AT hedgesjodif intrinsicsignalamplificationbytypeiiicrisprcassystemsprovidesasequencespecificsarscov2diagnostic AT cichacalvin intrinsicsignalamplificationbytypeiiicrisprcassystemsprovidesasequencespecificsarscov2diagnostic AT leehelenh intrinsicsignalamplificationbytypeiiicrisprcassystemsprovidesasequencespecificsarscov2diagnostic AT grahamava intrinsicsignalamplificationbytypeiiicrisprcassystemsprovidesasequencespecificsarscov2diagnostic AT jutilamarka intrinsicsignalamplificationbytypeiiicrisprcassystemsprovidesasequencespecificsarscov2diagnostic AT taylormatthewp intrinsicsignalamplificationbytypeiiicrisprcassystemsprovidesasequencespecificsarscov2diagnostic AT wiedenheftblake intrinsicsignalamplificationbytypeiiicrisprcassystemsprovidesasequencespecificsarscov2diagnostic |